A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly untapped but growing market for hair ...

The success of GLP-1 drugs is reshaping discussion around endometriosis treatment and the future of the women’s health market ...

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.

Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...

Barriers GLP-1 adherence systems face include cost, side effects, and care models; health systems use structured ...

A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight ...

U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGRAustin, May 05, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Ozempic Market size was valued ...

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

Gross profit margin -- 79%, down from 81%, with higher shipping, warehouse, and inventory obsolescence costs; adjusted ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

GLP‑1 adoption is changing how consumers eat. Here’s how dairy innovation is shifting toward protein density, digestive ...